Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Potency of several retinoids assessed in bladder cancer cell lines

May 9, 2001

Enzon begins patient treatment in phase I trial of PEG-paclitaxel

May 9, 2001

MGI's lead acylfulvene advances to phase II for refractory sarcoma

May 9, 2001

Preclinical profile of Bay-59-8862, a new taxane, reviewed in Drugs of the Future

May 8, 2001

MAbs prepared at Genentech act as HGF receptor antagonists

May 8, 2001

Cell Pathways and BMS to initiate drug combination study for first-line NSCLC

May 8, 2001

Preclinical antiproliferative activity of A-105972 characterized

May 8, 2001

Phase II trial of irofulven for treatment of glioma commences

May 8, 2001

Pharmacyclics reacquires worldwide rights to Lutrin

May 8, 2001

New kinase inhibitors under study at Pfizer

May 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...